Einrichtungen, die zum Universitätsklinikum Erlangen gehören


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Rheological Analysis of Saliva Samples and its Influence on Voice Quality in Ectodermal Dysplasia (2024) Semmler M, Eckhardt M, Heinrich A, Tur B, Wolfsteiner S, Schlicht S, Drummer D, et al. Conference contribution, Conference Contribution Vibratory Response of an Adaptive Synthetic Larynx Model (2024) Tur B, Gühring L, Wendler O, Schlicht S, Drummer D, Schützenberger A, Kniesburges S Conference contribution, Original article Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort (2024) Stamellou E, Nadal J, Hendry B, Mercer A, Bechtel-Walz W, Schiffer M, Eckardt KU, et al. Journal article Single-cell analysis reveals lasting immunological consequences of influenza infection and respiratory immunization in the pig lung (2024) Muir A, Paudyal B, Schmidt S, Sedaghat-Rostami E, Chakravarti S, Villanueva-Hernández S, Moffat K, et al. Journal article Understanding the genetic complexity of puberty timing across the allele frequency spectrum (2024) Kentistou KA, Kaisinger LR, Stankovic S, Vaudel M, Mendes de Oliveira E, Messina A, Walters RG, et al. Journal article Application of Near Infrared Spectroscopy to Enhance Safety and Individualize Distraction of Severely Contracted Joints in Far-Advanced Dupuytren’s Disease (2024) Müller-Seubert W, Cai A, Horch RE Journal article Exploring membranous NECTIN-4 expression patterns and enfortumab vedotin response in prostate cancer (2024) Weiten R, Bernhardt M, Niemann M, Kristiansen G, Grünwald V, Ritter M, Hölzel M, et al. Journal article 177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study (2024) Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel ME, Kunz PL, Chasen B, et al. Journal article Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study (2024) Taylor PC, Schett G, Huizinga TW, Wang Q, Ibrahim F, Zhou B, Liva SG, et al. Journal article Ophthalmological research in Germany: suggestions by an international expert panel (2024) Ader M, Cursiefen C, Fauser S, Gliem M, Helbig H, Lagrèze W, Marshall J, et al. Journal article